北方國際(000065.SZ):目前已總承包和投建了克羅地亞塞尼風電等六十多個“一帶一路”重大標誌性項目
格隆匯5月16日丨有投資者在投資者互動平台向北方國際(000065.SZ)提問,“今年即將舉辦第三屆一帶一路國際合作高峯論壇,對公司有什麼影響?”
北方國際回覆稱,2023年是共建“一帶一路”倡議提出10週年,北方國際目前已總承包和投資建設了巴基斯坦橙線地鐵、克羅地亞塞尼風電、孟加拉1320MW燃煤電站、蒙古礦山一體化等六十多個“一帶一路”重大標誌性項目。今年舉辦第三屆“一帶一路”國際合作高峯論壇,將會使我國高質量共建“一帶一路”的倡議得到普遍支持和廣泛響應,為國際工程行業帶來發展機遇,公司也希望通過峯會的獲得新的項目機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.